Results 21 to 30 of about 1,217,759 (290)

COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study

Vaccines, 2022
Background: Vaccination has been effective in preventing COVID-19 infections and related mortality. However, waning immunity after two-dose vaccination prompted health authorities to recommend a third dose of COVID-19 vaccine to boost immunity.
Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli   +2 more
doaj   +1 more source

Evaluation of Antibody Response and Adverse Effects following Heterologous COVID-19 Vaccine Booster with mRNA Vaccine among Healthcare Workers in Indonesia

Vaccines, 2023
Background: The administration of the third (or booster) dose of COVID-19 vaccine is important in maintaining protection against SARS-CoV-2 infection or the severity of the disease.
Gatot Soegiarto, Bagus Aulia Mahdi, Laksmi Wulandari, Karin Dhia Fahmita, Satrio Tri Hadmoko, Hendra Ikhwan Gautama, Dewi Prasetyaningtyas, Muhammad Edwin Prasetyo, Pujo Prawiro Negoro, Nur Arafah, Dewajani Purnomosari, Damayanti Tinduh, Dominicus Husada, Ari Baskoro, Deasy Fetarayani, Wita Kartika Nurani, Delvac Oceandy   +16 more
doaj   +1 more source

Safety and Immunogenicity of a Heterologous Booster of Protein Subunit Vaccine MVC-COV1901 after Two Doses of Adenoviral Vector Vaccine AZD1222

Vaccines, 2022
We report the safety and immunogenicity results in participants administrated with a booster dose of protein subunit vaccine MVC-COV1901 at 12 (Group A) or 24 (Group B) weeks after two doses of AZD1222 (ChAdOx1 nCoV-19).
Shu-Hsing Cheng, Yi-Chun Lin, Cheng-Pin Chen, Chien-Yu Cheng   +3 more
doaj   +1 more source

Acceptance for a booster dose of COVID-19 vaccine in Indonesia: A follow-up study. [PDF]

Narra J
The coronavirus disease 2019 (COVID-19) vaccination program in Indonesia has been implemented as a key strategy to mitigate the spread of the virus within communities.
Harapan H, Maelani I, Anwar S, Latief K, Mellinia SA, Nanda CM, Nainu F, Nirwana A, Aksa R, Sarifuddin S, Astri Y, Fathima R, Nalapraya WY, Ikram I, Mutiara S, Syahraini A, Mudatsir M.   +16 more
europepmc   +2 more sources

Booster dose vaccination for preventing hepatitis B [PDF]

Cochrane Database of Systematic Reviews, 2016
Antibodies against hepatitis B surface antigen (HBsAg) wane over time following hepatitis B immunisation; hence, it is unclear whether people vaccinated in three-dose or four-dose schedules of the hepatitis B vaccine are still immune when the hepatitis B surface antibody (anti-HBs) level in their body is undetectable, or lower than the level usually ...
Jalal, Poorolajal, Elham, Hooshmand
openaire   +2 more sources

Omicron and vaccine booster dose – an update

Indian Journal of Community Health, 2022
Mutations in coronavirus is not unheard off. The variant, Omicron B.1.1.529 has overall 50 mutations and is considered as a variant of concern. Though the new variant has shown changes throughout its genome, S gene changes predominate. Significant changes in the S encoding gene, S gene, influences not only the transmissibility properties of SARS-CoV-2 ...
Pushpa Nagavalli Basavanna, Hatur Basavanagowdappa, Archana Siddaiah, Apurba Patra, Viveka Srinivasan, Sudha Makam Janardhan, Rachna Pasi, Kumar Satish Ravi   +7 more
openaire   +1 more source

COVID-19 Vaccine Booster Hesitancy among Healthcare Workers: A Retrospective Observational Study in Singapore

Vaccines, 2022
Background: COVID-19 booster uptake remained poor among healthcare workers (HCW) despite evidence of improved immunity against Delta and Omicron variants.
Sky Wei Chee Koh, Hwei Ming Tan, Wayne Han Lee, Jancy Mathews, Doris Young   +4 more
doaj   +1 more source

Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial [PDF]

, 2014
BACKGROUND: In a previous UK multi-center randomized study 278 children received three doses of 7-valent (PCV-7) or 13-valent (PCV-13) pneumococcal conjugate vaccine at 2, 4 and 12 months of age.
Trück, J, Yu, Ly-Mee, Finn, Adam, Ly-Mee Yu (44961), Pollard, Andrew J, Pollard Andrew J., Trück, Johannes; https://orcid.org/, Faust, Saul N, Johannes Trück, Merryn Voysey, Paul T. Heath (533551), Yu Ly-Mee, Voysey, M, Saul N. Faust (415924), Tatangeli, F, Andrew J Pollard, Voysey Merryn, Heath Paul T., Tatangeli, Florencia, Adam Finn (23223), Florencia Tatangeli (533550), Faust, S.N., Snape, MD, Pollard, AJ, Pollard, Andrew, Heath, PT, Adam Finn, Snape, Matthew, Merryn Voysey (255058), Faust Saul N., Andrew J. Pollard (44971), Snape Matthew D., Heath, Paul T, Voysey, Merryn, Yu, LM, Paul T Heath, Finn Adam, Tatangeli Florencia, Matthew D. Snape (533549), Faust, SN, Matthew D Snape, Finn, A, Snape, Matthew D, Florencia Tatangeli, Saul N Faust, Pollard, Andrew J., Ly-Mee Yu, Johannes Trück (533548), Truck, Johannes, Trück Johannes, Heath, Paul   +50 more
core   +1 more source

Comparison of the rapidity of SARS-CoV-2 immune responses between primary and booster vaccination for COVID-19 [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims The rapidity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific memory B or T cell response in vaccinated individuals is important for our understanding of immunopathogenesis of coronavirus disease 2019 (COVID-19 ...
Ji Yeun Kim, Ji-Soo Kwon, Hye Hee Cha, So Yun Lim, Seongman Bae, Sung-Han Kim   +5 more
doaj   +1 more source

COVID Booster Shot and the Third Dose [PDF]

Journal of Medical Research and Surgery, 2021
The protection provided by the original shot(s) has begun to decrease over time, then a Coronavirus Disease (COVID) booster shot is given. Moreover, the immunity from the initial dose(s) naturally starts to wane, and you would get a booster. Accordingly, the booster is designed in order to maintain the people’s level of immunity for longer [1].
openaire   +1 more source